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The hepatoprotective potential of hispolon against carbon tetrachloride (CCl4)-induced liver damage was evaluated in preventive
models in rats. Male rats were intraperitoneally treated with hispolon or silymarin once daily for 7 consecutive days. One hour
after the ﬁnal hispolon or silymarin treatment, the rats were injected with CCl4. Administration with hispolon or silymarin
signiﬁcantlydecreasedthealanineaminotransferase(ALT)andaspartateaminotransferase(AST)levelsinserumandincreasedthe
activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), and glutathione (GSH) content and decreased
the malondialdehyde (MDA) content in liver compared with CCl4-treated group. Liver histopathology also showed that hispolon
reduced the incidence of liver lesions induced by CCl4. In addition, hispolon decreased nitric oxide (NO) production and tumor
necrosis factor (TNF-α), inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) activation in CCl4-treated rats. We also
examined the involvement of matrix metalloproteinase (MMP)-9 in the development of CCl4-induced liver damage in rats.
Hispolon inhibited the expression of MMP-9 protein, indicating that MMP-9 played an important role in the development of
CCl4-induced rat liver damage. Therefore, we speculate that hispolon protects rats from liver damage through their prophylactic
redox balancing ability and anti-inﬂammation capacity.
1.Introduction
It has been reported that liver injuries induced by carbon
tetrachloride (CCl4) are the best characterized system
of xenobiotic-induced hepatotoxicity and commonly used
model for the screening of antihepatotoxic and hepatopro-
tective activities of drugs [1]. The principal cause of CCl4-
induced hepatic damage involves increased lipid peroxida-
tion, decreased activities of antioxidant enzymes, and bio-
transformation of free radical derivatives [2]. CCl4-induced
hepatotoxicity is believed to involve two phases. The ﬁrst
involvescytochromeP4502E1-mediatedmetabolismoftoxic
metabolite trichloromethyl radical (CCl3
•) to a highly reac-
tive trichloromethyl peroxy radical (CCl3OO
•), which initi-
ates lipid peroxidation and leads to peroxidative degradation
of cellular membrane leading to the necrosis of hepatocytes
[3]. The second step involves the activation of Kupﬀer cells,
probably by free radicals [4]. The activation of Kupﬀer
cells is accompanied by the production of proinﬂammatory
mediators [5]. As a result of the hepatic injury, the altered2 Evidence-Based Complementary and Alternative Medicine
permeability of the membrane causes the enzymes within
the cells to be released into circulation, which damages the
hepatic cells, as shown by the abnormally high level of serum
hepatospeciﬁc enzymes.
Those inﬂammatory mediators from activated hepatic
macrophages are thought to potentiate CCl4-induced hep-
atic damage [6], and macrophages could be involved in the
release of a number of inﬂammatory mediators contributing
to xenobiotic-induced tissue injury [7]. Two mediators of
i n t e r e s ta r et u m o rn e c r o s i sf a c t o r - α (TNF-α) and nitric
oxide (NO). TNF-α is unique among cytokines in which
it can induce cytotoxicity directly and has been implicated
in apoptosis [8]. NO is a highly reactive oxidant, produced
by parenchymal and nonparenchymal liver cells from L-
arginine via the action of inducible nitric oxide synthase
(iNOS) [9]. When released by macrophages against infec-
tious agents, nitric oxide has been shown to inhibit mito-
chondrial respiration and DNA synthesis [10]. Macrophages
and inﬂammatory mediators including TNF-α and NO have
been implicated in liver damage induced by a number of
diﬀerent toxicants [7].
Matrix metallopeptidases (MMPs), a family of zinc- and
calcium-dependent proteinases, participates in the degrada-
tion of extracellular matrix (ECM) [11]. Various cell types
such as neutrophils, macrophages, and hepatic satellite cells
have been demonstrated to produce MMPs around hepato-
cyte damaged sites [12]. Recently, increasing discoveries of
activities involving MMP-2 and -9 in the liver have been
reportedinanimalhepatitismodels[13].Therefore,abroad-
spectrum MMP inhibitor may be potentially useful for the
treatment of patients with acute and perhaps chronic liver
failure.
Phellinus linteus (Berk. & M.A. Curt.) (PL) is a mush-
room that belongs to the genus Phellinus and is commonly
called “Sangwhang” in Taiwan. It is popular in oriental
countries and has been traditionally used as food and
medicine. PL contains many bioactive compounds and is
known to improve health and to prevent and to remedy
various diseases, such as gastroenteric disorders, lymphatic
diseases,andcancer[14].Werecentlyreportedthathispolon,
a phenol compound isolated from PL, anti-inﬂammatory,
antiproliferative, and antimetastatic eﬀects [15]. The objec-
tive of this study was to understand more about the
protective eﬀects of hispolon on CCl4-induced rat liver
damage. In addition, we examined the enzyme expression of
MMP-9 in CCl4-induced rat liver damage and the eﬀect of
hispolon on MMP-9 expression in this model.
2.MaterialsandMethods
2.1. Chemicals. CCl4 was purchased from Merck(Germany).
Silymarin and other chemicals were purchased from Sigma
Chemical Co (Steinheim, Germany). Biochemical assay kits
(ALT kit; AST kit; SOD kit; GPx kit) were purchased from
Randox Laboratories (Crumlin, UK). TNF-α was purchased
from Biosource International Inc., (Camarillo, Calif, USA).
The antibody against iNOS, COX-2, MMP-9, and β-actin
were purchased from Cell Signaling Technology (Beverly,
Mass, USA).
OH
OH
HO
O
Figure 1: Chemical structure of hispolon.
2.2. Isolation and Characterization of Hispolon from Fruiting
Body of PL. The fruiting body of PL (about 1.0kg, air dry
weight) was powdered and extracted with 95% EtOH 6L at
room temperature (3 times, 72h each). Extracts were ﬁltered
a n dc o m b i n e dt o g e t h e ra n dt h e ne v a p o r a t e da t4 0 ◦C (N-11,
Eyela, Japan) to dryness under reduced pressure to give a
dark brownresidue (40g). Theyield obtained forPL is about
4%. The crude extract was suspended in H2O (1 L), and then
partitioned with 1L n-hexane (×2), 1 L EtOAc (×2), and 1 L
n-butanol (×2), successively.
Hispolon was puriﬁed from the EtOAc soluble portion
(8g) by a bioassay-guid separation. A portion of the active
EtOAc fraction was subjected to silica gel chromatogra-
phy using stepwise CHCl3-MeOH (9:1, 8:2, 1:1 v/v)
as eluent. Final puriﬁcation was achieved by preparative
HPLC (Spherisorb ODS-2 RP18, 5 μm; Promochem), 250
× 25mm, acetonitrie-H2O( 8 3 : 1 7v / v ) ,a taﬂ o wr a t eo f
10mL/min and UV detection at 375nm. The identiﬁcation
of hispolon (Figure 1) was performed by comparing their
physical spectral data with the literature values [16].
2.3. Animal Treatment. Male Sprague-Dawley (SD) rats,
weighing 180–200g (6–8 weeks old), were maintained at
25 ± 2
◦C with a 12h light/dark cycle and fed with a standard
rat chow and water ad libitum. Being divided into six groups
(n = 8), normal and negative control groups were orally
administered with distilled water. The positive control group
was orally administered with silymarin (200mg/kg in 1%
carboxymethyl cellulose) once daily for 7 days. In the three
experimental groups, the rats were intraperilotneally (i.p.)
pretreatedwithhispolon(5,10,and20mg/kg,i.p.)oncedaily
for seven consecutive days. One hour after the last treatment
of hispolon and silymarin, all the rats were treated with
CCl4 (1.5mL/kg in olive oil, 20%, i.p.). 24h after the CCl4
treatment, animals were anesthetized with ethyl ether and
blood samples were collected through their carotid arteries.
Animal studies were conducted according to the regulations
of the Institutional Animal Ethics Committee (IAEC) of
China Medical University, Taichung, Taiwan.
2.4. Assessment of Liver Functions. To assess hepatotoxicity,
serum activity of AST and ALT were measured using
spectrophotometric diagnostic kits according to the manu-
facturer’s recommendations. The blood was centrifuged at
1700×g (Beckman GS-6R, Germany) at 4◦Cf o r3 0m i n u t e s
to separate serum. ALT and AST were analyzed. Liver tissuesEvidence-Based Complementary and Alternative Medicine 3
collected from the animals were stored at 10% formalin for
histopathological studies. Also, liver tissues were kept under
−80◦C for further analysis of their enzyme levels. The bio-
chemical parameters were analyzed by Spectrophotometer
(Roche Cobas Mira plus, Germany) using clinical test kits.
2.5. Histopathological Examination. Small pieces of liver,
ﬁxed in 10% buﬀered formalin were processed for embed-
ment in paraﬃn. Sections of 4-5μm were cut and stained
with hematoxylin and eosin and then examined for
histopathological changes under the microscope (Nikon,
ECLIPSE, TS100, Japan). Images were taken with a digital
camera (NIS-Elements D 2.30, SP4, Build 387) at original
magniﬁcation of ×200.
2.6. Antioxidant Enzyme Activity Measurements. The follow-
ing biochemical parameters were analyzed to check the hep-
atoprotective activity of hispolon by our previous methods
[17]. Liver homogenates were prepared in cold Tris-HCl
(5mM containing 2mM EDTA, pH 7.4) using a homoge-
nizer. The unbroken cells and cell debris were removed by
centrifugationat12,000gfor30minat4◦C.Thesupernatant
was used immediately for the assays of SOD, catalase, GPx,
and GSH. All of these enzymes were determined following
the instructions on the Randox Laboratories Ltd kit.
2.7. Hepatic Glutathione (GSH) Activity. Hepatic GSH level
was determined as described previously [17] with slight
modiﬁcations. Brieﬂy, 720μL of the liver homogenate in
200mM Tris-HCl buﬀer (pH 7.2) was diluted to 1440μL
withthesamebuﬀer.FivepercentTCA(160μL)wasaddedto
it and mixed thoroughly. The samples were then centrifuged
at 10,000g for 5min at 4◦C. Supernatant (330μL) was taken
in a tube and 660μLo fE l l m a n ’ sr e a g e n t( D T N B )s o l u t i o n
was added to it. Finally the absorbance was taken at 405nm.
2.8. Lipid Peroxidation Intermediates. The malondialdehyde
(MDA) content, a measure of lipid peroxidation, was
assayedintheformofthiobarbituricacid-reactivesubstances
(TBARS) as previously described [17]. Brieﬂy, 1g of liver
was homogenized in 10mL of KCl 1.15% (w/v), and
the homogenate was ﬁltered through fourfolded gauze. A
volume of 0.5mL of liver homogenate was mixed with
3mL of H 3PO4 1% (v/v) and 1mL of thiobarbituric acid
(TBA) 0.6% (w/v) and then heated to and maintained
at 100◦C for 45min. The samples were allowed to reach
room temperature and 3mL of n-butanol was added. After
shaking vigorously with the vortex, the butanolic phase
was obtained by centrifugation at 4,000×gf o r1 0 m i nt o
determinate the absorbance at 535nm. The standard was 1,
1, 1, 3-tetraethoxypropane. The protein concentration of the
sample was determined by the Bradford dye-binding assay
(Bio-Rad, Hercules, Calif, USA).
2.9. Measurement of Serum TNF-α by ELISA. Serum levels
of TNF-α were quantiﬁed by using a commercially available
enzyme-linkedimmunosorbentassay(ELISA)kit(Biosource
International Inc., Camarillo, Calif, USA.) according to the
manufacturer’s instruction. TNF-α was quantiﬁed from a
standardcurve.Theconcentrationswereexpressedaspg/mL.
2.10. Measurement of Nitric Oxide/Nitrite. The production
of NO was assessed indirectly by measuring the nitrite
levels in the plasma by a calorimetric method based on
the Griess reaction [17]. Plasma samples were diluted four
times with distilled water and deproteinized by adding 1/20
volume of zinc sulfate (300g/L) to a ﬁnal concentration
of 15g/L. After centrifugation at 10,000×gf o r5 m i na t
room temperature, 100μL supernatant was applied to a
microtiter plate well, followed by 100μL of Griess reagent
(1% sulfanilamide and 0.1% N-1-naphthylethylenediamine
dihydrochloride in 2.5% polyphosphoric acid). After 10min
of color development at room temperature, the absorbance
was measured at 540nm with a MicroReader (Hyperion,
Inc., FL, U.S.A.). Sodium nitrite (0.5–20μM) was used to
create a standard calibration curve.
2.11. Examination Activity of Matrix Metalloproteinase-9
(MMP-9) by Gelatin Zymography. The activity of MMP-9 in
the medium was measured by gelatin zymography protease
assay as previously described [18]. Brieﬂy, the supernatant
of liver homogenization (10μg) was prepared with SDS
sample buﬀer without boiling or reduction, and then it was
subjected to 0.1% gelatin-8% SDS-PAGE electrophoresis.
After electrophoresis, the gel was washed with 2.5% Triton
X-100 and then incubated in a reaction buﬀer (40mM Tris-
HCl, pH 8.0; 10mM CaCl2 and 0.01% NaN3)a t3 7 ◦Cf o r
12h, then the gel was stained with Coomassie brilliant blue
R-250.
2.12. Protein Lysate Preparation and Western Blot Analysis of
iNOS, COX-2, and MMP-9. Liver tissues were homogenized
in lysis buﬀer (0.6% NP-40, 150mM NaCl, 10mM HEPES
(pH 7.9), 1mM EDTA, and 0.5mM PMSF) at 4◦C. BSA
(bovine serum albumin) was applied as a protein standard.
Protein samples (30μg) were resolved by denaturing sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) using standard methods and then were transferred
to PVDF membranes by electroblotting and blocking with
1% BSA. The membranes were probed with the primary
antibodies, (iNOS, COX-2, MMP-9, and β-actin) at 4◦C
overnight, washed three times with PBST, and incubated
f o r1ha t3 7 ◦C with horseradish peroxidase-conjugated sec-
ondary antibodies. The membranes were washed three times
and the immunoreactive proteins were detected by enhanced
chemiluminescence (ECL) using hyperﬁlm and ECL reagent
(Amersham International PLC, Buckinghamshire, UK). The
results of Western blot analysis were quantiﬁed by measuring
the relative intensity compared to the control using Kodak
Molecular Imaging software and represented in the relative
intensities.
2.13. Statistical Analysis. All data were presented as mean ±
S.D. from three independent experiments. Means of tripli-
cates were calculated. Student’s t-test was used for compar-
ison between two treatments. A diﬀerence was considered4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀect of hispolon on the activities of serum AST and ALT in CCl4-injected rats. Animals were i.p. treated with hispolon (5, 10, and
20mg/kg) once daily for consecutive seven days. One hour after the ﬁnal hispolon treatment, the rats were injected with CCl4 (1.5mL/kg,
i.p.). The rats were killed 24h after the CCl4 injection. Hepatotoxicity was determined by quantifying the serum activities of aspartate
aminotransferase (AST) and alanine aminotransferase (ALT). The values are reported as the mean ± S.D. of six rats per group. ###P<0.001
compared with control; ∗∗∗P<0.001 compared with the CCl4 group.
to be statistically signiﬁcant when P<0.05, P<0.01, or
P<0.001.
3. Results
3.1. Eﬀects of Hispolon on Serum AST and ALT Activities.
Several hepatic enzymes in serum such as AST and ALT
in liver homogenate were used as the biochemical markers
for the early acute hepatic damage. The levels of AST and
ALT were measured in the serum to evaluate hepatic tissue
damage. CCl4 administration resulted in signiﬁcant (P<
0.001) rise in the levels of AST and ALT when compared with
the control group. Preadministration with hispolon (i.p.)
at three diﬀerent doses (5, 10, and 20mg/kg) signiﬁcantly
preventedtheincreasedserumASTandALTlevels.Silymarin
(a positive control) at a dose of 200 mg/kg also prevented the
elevation of AST and ALT (Figure 2).
3.2. Histopathological Analysis. Results from the histological
studies were in agreement on the serum AST and ALT
levels. There were no abnormalities or histological changes
in the livers of normal rats (Figure 3(a)). Data showed that
CCl4 induceshistologicalchangesincludingincreaseddegen-
eration, necrosis, hepatitis, and portal triaditis. Vacuole
generation and microvascular steatosis were also observed
(Figure 3(b)). Compared with the lesions observed in the
CCl4 control group, the lesions of silymarin-treated rats
were of a much milder degree (Figure 3(c)). Pretreatment
with hispolon at 5, 10, and 20mg/kg reduced the severity
of CCl4-induced liver intoxication (Figures 3(d), 3(e),a n d
3(f)). All rats except those in the control group exhibited
the ballooning degeneration in the centrolobular zone and
the necrosis of hepatocytes (Figure 3). The CCl4-induced
damage suﬀered more severely than other groups pretreated
with hispolon.
3.3. Eﬀect of Hispolon on Hepatic Antioxidant Enzymes Activ-
ities. The superoxide dismutase (SOD), catalase (CAT),
and glutathione peroxidase (GPx) activities in CCl4-treated
rats were signiﬁcantly decreased, compared to the control.
Compared to CCl4 group, rats pretreated with hispolon at
5, 10, and 20mg/kg showed signiﬁcant increase in SOD
(Figure 4(a)), CAT (Figure 4(b)), and GPx (Figure 4(c)),
respectively. The reference protective drug silymarin-treated
rats also showed signiﬁcant increase in SOD, CAT, and GPx
when it was compared to CCl4-treated rats.
3.4. Eﬀect of Hispolon on Lipid Peroxidation in CCl4-Treated
Rat Liver. As shown in Figure 5(a), hepatic levels of TBARS
were assessed as an indicator of tissue lipid peroxidation.
CCl4 treatment signiﬁcantly increased the level of TBARS
in the liver. A signiﬁcant increase (P<0.001) in tissue
T B A R Sl e v e lw a so b s e r v e di nC C l 4 alone treated rats.
CCl4-induced elevation of tissue TBARS concentration was
lowered signiﬁcantly by the i.p. pretreatment of the rats
with hispolon. Hispolon at 5, 10, and 20mg/kg signiﬁcantly
prevented the increase in TBARS level when compared to
CCl4 group. Silymarin also protected the liver from elevating
TBARS levels and kept TBARS levels in normal values.
3.5. Eﬀects of Hispolon on Hepatic GSH Levels. Because the
oxidative stress pathway generally involves the GSH system,
we measured the level of GSH in each group. The adminis-
tration with CCl4 signiﬁcantly depleted GSH (P<0.001),
whereas treatment with hispolon (5, 10, and 20mg/kg) sig-
niﬁcantly and dose-dependently protected the liver againstEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Eﬀect of hispolon on the CCl4-induced liver damage. Animals were i.p. treated with the hispolon (5, 10, and 20mg/kg) once daily
for consecutive seven days. One hour after the ﬁnal hispolon treatment, the rats were treated with CCl4 (1.5mL/kg, i.p.). Rats were sacriﬁced
24h after the CCl4 administration and liver was removed, ﬁxed, and embedded in paraﬃn. Sections were stained with hematoxylin-eosin
(×100) and observed under the light microscopy. (a) Control; (b) CCl4 (0.5mL/kg); (c) silymarin (200mg/kg)+ CCl4 (0.5mL/kg); (d)
hispolon (5mg/kg)+ CCl4 (0.5mL/kg); (e) hispolon (10mg/kg)+ CCl4 (0.5mL/kg); (f) hispolon (20mg/kg)+CCl4 (0.5mL/kg).
this eﬀect (Figure 5(b)). Silymarin-treated rats also showed
signiﬁcant increased GSH level in liver homogenates when
compared with CCl4 group.
3.6. Eﬀect of Hispolon on the Serum TNF-α Level in CCl4-
Treated Rats. As shown in Figure 6(a), the level of serum
TNF-α was 64.59 ± 7.32pg/mL in control group. CCl4
treatment caused signiﬁcant (P<0.001) increase in the
serum TNF-α levels when compared with control group.
Pretreatment with hispolon at the doses of 5, 10, and
20mg/kg resulted in signiﬁcant decrease of TNF-α content
when compared to CCl4-treated rats. Silymarin-treated rats
also showed signiﬁcant (P<0.01) decrease in TNF-α level in
serum compared with CCl4-treated rats.
3.7. Eﬀe c to fH i s p o l o no nS e r u mN OP r o d u c t i o ni nC C l 4-
Treated Rats. Production of NO in rat serum was sig-
niﬁcantly enhanced in CCl4-treated rats comparing to
the control group. However, pretreatment with hispolon
concentration dependently decreased the NO production
in CCl4-treated rats. For example, NO production in the
control group was 2.56 ± 0.22μM/mg protein, while it was
5.81 ± 0.13μM/mg protein with CCl4 treatment. However,
the NO production in the CCl4-treated rats was signiﬁcantly
(P<0.01) decreased to 5.04 ± 0.09, 4.49 ± 0.12, and
3.89±0.11μM/mgproteinwith5,10,and20mg/kghispolon
oral pretreatment, respectively (Figure 6(b)). Silymarin-
(200mg/kg) treated rats also showed signiﬁcant (P<0.001)
decrease in NO production in serum compared with CCl4
group.
3.8. Analysis of iNOS/COX-2 Expression Following Hispolon
Treatment in Rats with CCl4-Induced Liver Injury. We inves-
tigated the changes of the activation of iNOS and COX-
2b yh i s p o l o ni nC C l 4-treated rats (Figure 7). The results
showed that CCl4 treatment stimulates to increase activation
of iNOS and COX-2. For example, in CCl4 treatment group,
the relative intensity of iNOS and COX-2 band was increased
by 2.52- and 1.69-fold, compared to the control. However,
the treatment of hispolon decreased the iNOS and COX-
2 expression in CCl4-induced rats. Namely, the relative
intensitiesofbandsaboutiNOSandCOX-2expressionswere6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Eﬀect of hispolon on the hepatic antioxidant enzymes (SOD, CAT, and GPx) activities in CCl4-treated rats. Animals were i.p.
treated with hispolon (5, 10, and 20mg/kg) once daily for consecutive seven days. One hour after the ﬁnal hispolon treatment, the rats were
injected with CCl4 (1.5mL/kg, i.p.). The rats were killed 24h after the CCl4 injection. Hepatotoxicity was determined by quantifying the
hepatic antioxidant enzymes (SOD, CAT, and GPx). The values are reported as the mean ± S.D. of six rats per group. ###P<0.001, compared
with the control group; ∗P<0.05, ∗∗P<0.01, and ∗∗P<0.001 compared with the CCl4 group.
reduced by 1.55- and 1.06-fold at 20mg/kg of hispolon,
respectively, compared to CCl4 treatment alone.
3.9. Eﬀect of Hispolon on Serum MMP-9 Activations in CCl4-
Treated Rats. The eﬀect of hispolon on MMP-9 activa-
tion was analyzed by gelatin zymography. As shown in
Figure 8(a), MMP-9 secretion was signiﬁcantly induced by
CCl4 treatment and suppressed by hispolon (20mg/kg)
pretreatment (P<0.01). In the zymography assay, it was
found that hispolon eﬀectively reduced MMP-9 expression
in the liver of animals with CCl4-induced hepatic damage in
a dose-dependent manner (Figure 8(b)).
3.10.EﬀectofMMP-9ExpressionsbyHispoloninCCl4-Treated
Rats Liver. The eﬀect of MMP-9 expression by hispolon
in rat liver was assessed by Western blotting. Rats were
pretreated with 5, 10, and 20mg/kg hispolon for 7 days,
and induced by CCl4 treatment for 24h. MMP-9 expression
was markedly induced in CCl4-treated group. And MMP-9
expression was suppressed by hispolon (20mg/kg) pretreat-
ment (P<0.001) (Figures 8(c) and 8(d)).
4. Discussion
This paper demonstrated that hispolon signiﬁcantly attenu-
ated CCl4-induced hepatotoxicity of the rats. CCl4-induced
liver damage involved the biotransformation of CCl4 by the
cytochrome P450 (CYPs) system into a trichloromethyl free
radical (CCL3
•) which causes lipid peroxidation, disrupts
Ca2+ homeostasis, and eventually kills cells [19]. ManyEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: Eﬀect of hispolon on TBARS formation (a) and GSH levels (b) in CCl4-injected rats. The values are reported as the mean ± S.D.
of six rats per group. ###P<0.001, compared with the control group; ∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001 compared with the CCl4
group.
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Figure 6: Eﬀect of hispolon on the serum TNF-α (a) and NO (b) level in CCl4-injected rats. The values are reported as the mean ± S.D. of
six rats per group. ###P<0.01 as compared to control group; ∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001 as compared to CCl4-treated group.
studieshaveshownthathepatoprotectiveeﬀectsmaybeasso-
ciated with an antioxidant capacity [20]. Our results demon-
strate that CCl4 treatment alone and post-treatment after 24
hours caused severe acute liver damage in rats, as evidenced
by increased serum ALT and AST activities (Figure 2).
Elevated levels of serums ALT and AST are indication
of cellular leakage and loss of functional integrity of cell
membrane in liver [20]. The leakage of large quantities
of enzymes into the blood stream was associated with
massive centrilobular necrosis, ballooning degeneration, and
cellularinﬁltrationoftheliver.Administrationwithhispolon
decreased the serum levels of ALT and AST towards their
respective normal value that is an indication of stabilization
of plasma membrane as well as repair of hepatic tissue
damagecausedbyCCl4 (Figures2and3).Theseresultsimply
that hispolon tends to prevent damage and suppressed the
leakage of enzymes through cellular membranes, and the
phenomenon was conﬁrmed by histological evidences.
Our results demonstrate that hispolon could exert its
protective eﬀect against CCl4-induced hepatotoxicity. And
this could be explained that hispolon enhance antioxidative
defense. Our previous studies demonstrate that hispolon
decreased the paw edema at the fourth and ﬁfth hours after
λ-carrageenin administration and increased the activities of8 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Eﬀect of hispolon on CCl4-injected the activation of iNOS (a) and COX-2 (b) in rats. The relative intensities were evaluated by
iNOS and COX-2 (c) proteins with the use of the Kodak Molecular Imaging software. β-Actin was used as internal control for equal loading
of proteins. The values are reported as the mean ± S.D. of six rats per group. ###P<0.001 as compared to control group; ∗∗∗P<0.001 as
compared to CCl4 group.
SOD, GPx, and glutathione reductase (GRx) in the liver
tissue. These anti-inﬂammatory mechanisms of hispolon
might be related to the decrease in the level of MDA in the
edema paw by increasing the activities of SOD, GPx, and
GRx in the liver. It probably exerts anti-inﬂammatory eﬀects
throughthesuppression ofTNF-αandNO[17].Andwealso
found that hispolon, a phenolic compound from Phellinus
merrillii,exhibitedantioxidantactivity.Phenoliccompounds
possess antioxidant, radical scavenging, and antimutagenic
and anticarcinogenic properties [21].
Many studies have demonstrated that antioxidant
e n z y m e ss u c ha sS O D ,C A T ,a n dG P xr e p r e s e n to n ep r o t e c -
tion against oxidative tissue damage [21]. SOD is an eﬀective
defense enzyme that converts the dismutation of superoxide
anions into hydrogen peroxide (H2O2)[ 22]. Then, CAT
metabolizes H2O2 to O2 and H2O. GPx detoxiﬁcates the
xenobiotics in the liver and catalyses the reduction of H2O2
and hydroperoxides to nontoxic products. These antioxidant
enzymes are inactivated by lipid peroxides or ROS, which
results in decreased activities of these enzymes in CCl4
toxicity [23]. In the present study, SOD, CAT, and GPx
activities were signiﬁcantly decreased in the liver in response
to CCl4 treatment alone compared with normal control rats,
implying increased oxidative damage to the liver (Figure 4).
In contrast, SOD, CAT, and GPx levels were signiﬁcantly
elevated by administration of hispolon to CCl4-intoxicated
rats,suggestingthatithastheabilitytorestoretheseenzymes
activities in CCl4-damaged liver.
The toxic metabolite CCl3 radical binds covalently to
the macromolecules and causes peroxidative degradation of
cellular membrane leading to the necrosis of hepatocytes
[24]. Increase in TBARS levels, evident in our study, sug-
gests enhanced lipid peroxidation leading to tissue damage
and failure of antioxidant defense mechanisms to prevent
formation of excessive free radicals [25]. Treatment with
silymarin and hispolon signiﬁcantly reversed these changes
(Figure 5(a)).
GSH, a nonenzymatic antioxidant, reduces H2O2,h y -
droperoxides (ROOH) and xenobiotic toxicity [26]. GSH
is readily oxidized to glutathione disulﬁde (GSSG) by
the reaction with ROOH or xenobiotic compounds that
may subsequently cause the reduction of GSH level. The
GSSG is either rapidly reduced by GSH reductase and
NADPH or utilized in the protein-folding process in the
endoplasmic reticulum. There, GSSG is recycled by protein
disulﬁde isomerase to form GSH. Due to these recycling
mechanisms, GSH is a particularly eﬃcient intracellular
buﬀer for oxidative stress [27]. Our results indicated that
administration of hispolon caused a signiﬁcant increase in
activity of GSH (Figure 5(b)) present in the liver. This may
be due to the inhibitory eﬀects on cytochrome P450 and/or
promotion of its glucuronidation [28]. GSH constitutes the
ﬁrst line of defense against free radicals and is a critical
determinant of the tissue susceptibility to oxidative damage.
It has been reported that GSH plays a key role in detoxifying
the reactive toxic metabolites of CCl4 and that liver necrosis
begins when the GSH stores are depleted [29]. In this
study, CCl4 treatment decreases the hepatic GSH levels and
intraperitoneal hispolon pre-treatments restored the hepatic
GSH levels to its respective normal value (Figure 5(b)). The
eﬀect could be due either to the de novo synthesis of GSH, its
regeneration, or both.
The liver is a major inﬂammatory organ, and inﬂamma-
tory processes contribute to a number of pathological events
after exposure to various hepatotoxins. Kupﬀer cells release
proinﬂammatory mediators either in response to necrosisEvidence-Based Complementary and Alternative Medicine 9
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Figure 8:EﬀectofhispolononCCl 4-injectedratstheactivityofMMP-9expression.CCl4-injectedratsweretreatedwith5,10,and20mg/kg
of hispolon for 24h and then subjected to gelatin zymography to analyze the activities of MMP-9 in the liver (a). The relative intensities were
evaluated by MMP-9 (b) proteins with the use of the Kodak Molecular Imaging software. Western blot analysis of hispolon on CCl4-injected
rats the activation of MMP-9 in rats liver (c). The relative intensities were evaluated by MMP-9 (d) proteins with the use of the Kodak
Molecular Imaging software. β-actin was used as internal control for equal loading of proteins. The values are reported as the mean ± S.D.
of six rats per group.###P<0.01 as compared to control group; ∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001 as compared to CCl4-treated group.
or as a direct action by the activated hepatotoxins, which
are believed to aggravate CCl4-induced hepatic injury [7].
TNF-α, a pleiotropic proinﬂammatory cytokine, is rapidly
produced by macrophages in response to tissue damage.
While low levels of TNF-α may play a role in cell protection,
excessive amounts cause cell impairment. An increase in
the TNF-α level has been directly correlated with the
histological evidence of hepatic necrosis and the increase
in the serum aminotransferase levels [29]. Decicco et al.
[30] have reported the stimulation of TNF-α production
in both serum and liver following CCl4 administration,
and it is suggested that CCl
·
3 activates Kupﬀer cells to
releaseTNF-α.TN F - α alsostimulates thereleaseof cytokines
from macrophages and induces the phagocyte oxidative
metabolism and NO production. NO is a highly reactive
oxidant that is produced through the action of iNOS, and
plays a role in a number of physiological processes, such
as vasodilation, neurotransmission, and nonspeciﬁc host
defense [31]. NO can also exacerbate oxidative stress by
reacting with reactive oxygen species, particularly with the
superoxide anion and forming peroxynitrite. This study
conﬁrmed a signiﬁcant increase in the serum TNF-α protein
expression after CCl4 administration. These alterations were
attenuated by the intraperitoneal hispolon pretreatment
(Figure 6), which suggests that hispolon suppresses the TNF-
α protein secretion and/or enhances its degradation.
OverproductionofNOintheliverhasbeenimplicatedas
an important event in endotoxin shock and in other models10 Evidence-Based Complementary and Alternative Medicine
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Figure 9: Propose the mechanism of hispolon in CCl4-injected rats.
of hepatic inﬂammation and injury. NO is known to react
withsuperoxideradical,formingperoxynitrite,anevenmore
potent oxidizing agent [32]. Therefore, this endotoxin shock
may alter the balance existing between NO production and
its target proteins and enzymes, leading to GSH depletion,
free radical generation, and upregulation of iNOS [33].
Previous report demonstrated that CCl4 administration
increased NO level in the blood plasma or CCl4-treated
animals [34]. Similarly, under acute CCl4 intoxication we
revealedconsiderableNOlevelinbloodplasma(Figure 6(b))
and increased expression of iNOS (Figure 7(a)). Hispolon
prevented the accumulation of the plasma NO level in CCl4-
treated rats. And the treatment with hispolon leads to a
reduction in the expression level of both iNOS and COX-2.
This may in part be the result of the regulatory activity and
expression of NF-κB and need to be proved.
Monocytes, which are recruited to inﬂammatory sites,
must ﬁrst extravasate the vasculature by crossing the
endothelial basement membrane and transversing the ECM.
Theymigratetowardgradientsofsignals,whichareprovided
by bacterial products, cytokines, chemokines, ECM proteins,
and proteins deposited in the ECM and orient themselves
according to the summated eﬀect of these signals [35].
To enable their movement across the ECM, monocytes
degrade their proteins by secreting proteases, including
MMPs. Among the diﬀerent MMPs, MMP-9, which is
induced strongly by proinﬂammatory cytokines (e.g., TNF-
α), is associated speciﬁcally with monocyte/macrophage
migration [36]. In this study, the expression of protein for
MMP-9 in rat liver was induced by CCl4. There is evidence
for the involvement of MMPs in animal hepatitis models
[15]. Others have suggested that MMP-9 participates in the
paracetamol-induced hepatotoxicity mediated by sinusoidal
endothelial cell injury, which results in the impairment of
microcirculation [37]. It is known that MMPs cleave the
ECM, leading to the disintegration of tissue integrity and the
inﬁltration of neutrophils and macrophages [38]. The level
of protein for MMP-9 in liver, as well as the serum levels of
AST and ALT, began to increase 24h after CCl4 treatment,
suggesting that MMP-9 was involved in the development of
CCl4-induced liver damage. In this study, hispolon inhibited
the expression of MMP-9 in CCl4-induced liver damage.
Moreover, hispolon reduced inﬂammatory cell staining for
MMP-9 in liver damages. This study also suggested that
an inhibitory eﬀect of hispolon on liver damage may have
been due to the prevention of MMP-9 production in the
development of acute hepatitis.
In conclusion, the results of this study demonstrate
that hispolon was eﬀective in prevention of CCl4-induced
hepatic damage in rats. Our results show that the hep-
atoprotective eﬀects of hispolon may be due to both the
inhibition of lipid peroxidation processes and the increase
of antioxidant enzymes activity. Hispolon could be also
involved in the modulation of proinﬂammatory cytokines
anddown-regulation of theexpression ofMMP-9(Figure 9).
Theinhibitory eﬀectsofadietary hispolon maybeusefulasa
hepatoprotective agent against chemical-induced hepatotox-
icity in vivo.
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